On June 23rd, Katherine Descant (PhD candidate in the Philpot Lab) was awarded an NRSA F31 Predoctoral Fellowship from the National Eye Institute entitled “Developing a gene therapy for IMPG2-associated retinal degeneration in a knockout mouse mode”. Congratulations, Katherine!
